Blog
-
DART project: novel mRNA delivery systems for vaccines
Published : 10/19/2026OZ Biosciences participates in the DART project, developing ionizable polymer-based mRNA delivery systems as an alternative to LNPs for vaccines.
-
Eurostars Project CAPSULIX: mRNA and LNPs for engineered cell therapy
Published : 10/14/2026The consortium composed of OZ Biosciences, ExploRNA, and Miltenyi Biotec will deliver a novel cell-based therapy manufacturing platform to treat cancer with CAR expressing T cells.
-
Our cationic poloxamers patent is now granted in Australia
Published : 09/09/2026Patent No. AU2020314617, “CATIONIC POLOXAMERS AND THEIR USE IN TRANSDUCTION,” covers our method for synthetically modifying poloxamers to confer additional biological properties...
-
Webinar: LNP Platform, from ionizable lipid design to custom & targeted delivery
Published : 06/03/2026Join us for a session covering LNP design principles, proprietary ionizable lipids, quality control, and comprehensive in vitro & in vivo performance data..
-
Partnership Opportunities
Published : 05/13/2026As new R&D programs take shape and funding opportunities emerge, we would like to highlight that we’re open to multiple collaboration models.
-
Webinar: mRNA platform - Explocap™, a new cap analog to extend synthesis scope
Published : 04/22/2026Explore mRNA applications, custom synthesis platform, available modifications, and cap analogs including ExploCap™ by ExploRNA Therapeutics, supported by in vivo data.
-
New Distribution Partnership
Published : 03/04/2026We’re thrilled to welcome Bio Medical Scientific Services LLC as our newest distribution partner!
-
New partnership with ExploRNA Therapeutics to strengthen our mRNA platform
Published : 02/03/2026This partnership marks an important milestone in strengthening our RNA platform and expanding high-performance solutions for the mRNA community.